TY - JOUR AU - Lo, J. S. AU - Snow, S. N. AU - Reizner, G. T. AU - Mohs, F. E. AU - Larson, P. O. AU - Hruza, G. J. PY - 1991 DA - 1991// TI - Metastatic basal cell carcinoma: Report of twelve cases with a review of the literature JO - J Am Acad Dermatol VL - 24 UR - https://doi.org/10.1016/0190-9622(91)70108-E DO - 10.1016/0190-9622(91)70108-E ID - Lo1991 ER - TY - JOUR AU - Chang, A. L. S. AU - Oro, A. E. PY - 2012 DA - 2012// TI - Initial assessment of tumor regrowth after vismodegib in advanced basal cell carcinoma JO - Arch Dermatol VL - 148 UR - https://doi.org/10.1001/archdermatol.2012.2354 DO - 10.1001/archdermatol.2012.2354 ID - Chang2012 ER - TY - JOUR AU - Sekulic, A. AU - Migden, M. R. AU - Oro, A. E. AU - Dirix, L. AU - Lewis, K. D. AU - Hainsworth, J. D. PY - 2012 DA - 2012// TI - Efficacy and safety of vismodegib in advanced basal-cell carcinoma JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1113713 DO - 10.1056/NEJMoa1113713 ID - Sekulic2012 ER - TY - JOUR AU - LoRusso, P. M. AU - Rudin, C. M. AU - Reddy, J. C. AU - Tibes, R. AU - Weiss, G. J. AU - Borad, M. J. PY - 2011 DA - 2011// TI - Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2745 DO - 10.1158/1078-0432.CCR-10-2745 ID - LoRusso2011 ER - TY - JOUR AU - Rodon, J. AU - Tawbi, H. A. AU - Thomas, A. L. AU - Stoller, R. G. AU - Turtschi, C. P. AU - Baselga, J. PY - 2014 DA - 2014// TI - A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor sonidegib (LDE225) in patients with advanced solid tumors JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-1710 DO - 10.1158/1078-0432.CCR-13-1710 ID - Rodon2014 ER - TY - JOUR AU - Hoff, D. D. AU - LoRusso, P. M. AU - Rudin, C. M. AU - Reddy, J. C. AU - Yauch, R. L. AU - Tibes, R. PY - 2009 DA - 2009// TI - Inhibition of the hedgehog pathway in advanced basal-cell carcinoma JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0905360 DO - 10.1056/NEJMoa0905360 ID - Hoff2009 ER - TY - JOUR AU - Lipson, E. J. AU - Forde, P. M. AU - Hammers, H. AU - Emens, L. A. AU - Taube, J. M. AU - Topalian, S. L. PY - 2015 DA - 2015// TI - Antagonists of PD-1 and PD-L1 in cancer treatment JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.05.013 DO - 10.1053/j.seminoncol.2015.05.013 ID - Lipson2015 ER - TY - STD TI - Winkler JK, Schneiderbauer R, Bender C, Sedlaczek O, Frohling S, Penzel R, et al. Anti-PD-1 therapy in nonmelanoma skin cancer. Br J Dermatol. 2016. doi:10.1111/bjd.14664. ID - ref8 ER - TY - JOUR AU - Ikeda, S. AU - Goodman, A. M. AU - Cohen, P. R. AU - Jensen, T. J. AU - Ellison, C. K. AU - Frampton, G. PY - 2016 DA - 2016// TI - Metastatic basal cell carcinoma with amplification of PD-L1: Exceptional response to anti-PD1 therapy JO - NPJ Genom Med VL - 1 UR - https://doi.org/10.1038/npjgenmed.2016.37 DO - 10.1038/npjgenmed.2016.37 ID - Ikeda2016 ER - TY - JOUR AU - Falchook, G. AU - Leidner, R. AU - Stankevich, E. AU - Piening, B. AU - Bifulco, C. AU - Lowy, I. PY - 2016 DA - 2016// TI - Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810 JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0176-3 DO - 10.1186/s40425-016-0176-3 ID - Falchook2016 ER - TY - JOUR AU - Taube, J. M. AU - Anders, R. A. AU - Young, G. D. AU - Xu, H. AU - Sharma, R. AU - McMiller, T. L. PY - 2012 DA - 2012// TI - Co-localization of inflammatory response with B7-H1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003689 DO - 10.1126/scitranslmed.3003689 ID - Taube2012 ER - TY - JOUR AU - Danial, C. AU - Sarin, K. Y. AU - Oro, A. E. AU - Chang, A. L. PY - 2016 DA - 2016// TI - An investigator-initiated open-label trial of sonidegib in advanced basal cell carcinoma patients resistant to vismodegib JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1588 DO - 10.1158/1078-0432.CCR-15-1588 ID - Danial2016 ER - TY - JOUR AU - Rizvi, N. A. AU - Hellmann, M. D. AU - Snyder, A. AU - Kvistborg, P. AU - Makarov, V. AU - Havel, J. J. PY - 2015 DA - 2015// TI - Cancer immunology. mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa1348 DO - 10.1126/science.aaa1348 ID - Rizvi2015 ER - TY - JOUR AU - Jayaraman, S. S. AU - Rayhan, D. J. AU - Hazany, S. AU - Kolodney, M. S. PY - 2014 DA - 2014// TI - Mutational landscape of basal cell carcinomas by whole-exome sequencing JO - J Invest Dermatol VL - 134 UR - https://doi.org/10.1038/jid.2013.276 DO - 10.1038/jid.2013.276 ID - Jayaraman2014 ER - TY - JOUR AU - Wong, D. AU - Bishop, G. AU - Lowes, M. AU - Cooke, B. AU - Barnetson, R. AU - Halliday, G. PY - 2000 DA - 2000// TI - Cytokine profiles in spontaneously regressing basal cell carcinomas JO - Br J Dermatol VL - 143 UR - https://doi.org/10.1046/j.1365-2133.2000.03596.x DO - 10.1046/j.1365-2133.2000.03596.x ID - Wong2000 ER - TY - JOUR AU - Hunt, M. AU - Halliday, G. AU - Dea, W. AU - Cooke, B. AU - Barnetson, R. S. PY - 1994 DA - 1994// TI - Regression in basal cell carcinoma: An immunohistochemical analysis JO - Br J Dermatol VL - 130 UR - https://doi.org/10.1111/j.1365-2133.1994.tb06873.x DO - 10.1111/j.1365-2133.1994.tb06873.x ID - Hunt1994 ER - TY - JOUR AU - Walter, A. AU - Barysch, M. J. AU - Behnke, S. AU - Dziunycz, P. AU - Schmid, B. AU - Ritter, E. PY - 2010 DA - 2010// TI - Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-3136 DO - 10.1158/1078-0432.CCR-09-3136 ID - Walter2010 ER - TY - JOUR AU - Kaporis, H. G. AU - Guttman-Yassky, E. AU - Lowes, M. A. AU - Haider, A. S. AU - Fuentes-Duculan, J. AU - Darabi, K. PY - 2007 DA - 2007// TI - Human basal cell carcinoma is associated with Foxp3 & plus; T cells in a Th2 dominant microenvironment JO - J Invest Dermatol VL - 127 UR - https://doi.org/10.1038/sj.jid.5700884 DO - 10.1038/sj.jid.5700884 ID - Kaporis2007 ER - TY - JOUR AU - Alexandrov, L. B. AU - Nik-Zainal, S. AU - Wedge, D. C. AU - Aparicio, S. A. AU - Behjati, S. AU - Biankin, A. V. PY - 2013 DA - 2013// TI - Signatures of mutational processes in human cancer JO - Nature VL - 500 UR - https://doi.org/10.1038/nature12477 DO - 10.1038/nature12477 ID - Alexandrov2013 ER - TY - JOUR AU - Bonilla, X. AU - Parmentier, L. AU - King, B. AU - Bezrukov, F. AU - Kaya, G. AU - Zoete, V. PY - 2016 DA - 2016// TI - Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma JO - Nat Genet VL - 48 UR - https://doi.org/10.1038/ng.3525 DO - 10.1038/ng.3525 ID - Bonilla2016 ER - TY - JOUR AU - Sharpe, H. J. AU - Pau, G. AU - Dijkgraaf, G. J. AU - Basset-Seguin, N. AU - Modrusan, Z. AU - Januario, T. PY - 2015 DA - 2015// TI - Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.02.001 DO - 10.1016/j.ccell.2015.02.001 ID - Sharpe2015 ER - TY - JOUR AU - Le, D. T. AU - Azad, N. S. AU - Laheru, D. AU - Browner, I. S. AU - Wang, H. AU - Uram, J. N. PY - 2014 DA - 2014// TI - Phase 2 study of programmed death-1 antibody (anti-PD-1, MK-3475) in patients with microsatellite unstable (MSI) tumors JO - J Clin Oncol VL - 32 ID - Le2014 ER - TY - JOUR AU - Nghiem, P. T. AU - Bhatia, S. AU - Lipson, E. J. AU - Kudchadkar, R. R. AU - Miller, N. J. AU - Annamalai, L. PY - 2016 DA - 2016// TI - PD-1 blockade with pembrolizumab in advanced merkel-cell carcinoma JO - N Engl J Med VL - 374 UR - https://doi.org/10.1056/NEJMoa1603702 DO - 10.1056/NEJMoa1603702 ID - Nghiem2016 ER - TY - JOUR AU - Cabrera, T. AU - Garrido, V. AU - Concha, A. AU - Martin, J. AU - Esquivias, J. AU - Oliva, M. R. PY - 1992 DA - 1992// TI - HLA molecules in basal cell carcinoma of the skin JO - Immunobiology VL - 185 UR - https://doi.org/10.1016/S0171-2985(11)80086-0 DO - 10.1016/S0171-2985(11)80086-0 ID - Cabrera1992 ER - TY - JOUR AU - Otsuka, A. AU - Dreier, J. AU - Cheng, P. F. AU - Nageli, M. AU - Lehmann, H. AU - Felderer, L. PY - 2015 DA - 2015// TI - Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2110 DO - 10.1158/1078-0432.CCR-14-2110 ID - Otsuka2015 ER - TY - JOUR AU - Migden, M. R. AU - Guminski, A. AU - Gutzmer, R. AU - Dirix, L. AU - Lewis, K. D. AU - Combemale, P. PY - 2015 DA - 2015// TI - Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): A multicentre, randomised, double-blind phase 2 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70100-2 DO - 10.1016/S1470-2045(15)70100-2 ID - Migden2015 ER - TY - JOUR AU - Topalian, S. L. AU - Drake, C. G. AU - Pardoll, D. M. PY - 2015 DA - 2015// TI - Immune checkpoint blockade: A common denominator approach to cancer therapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.03.001 DO - 10.1016/j.ccell.2015.03.001 ID - Topalian2015 ER - TY - JOUR AU - Green, M. R. AU - Monti, S. AU - Rodig, S. J. AU - Juszczynski, P. AU - Currie, T. AU - O’Donnell, E. PY - 2010 DA - 2010// TI - Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing hodgkin lymphoma and primary mediastinal large B-cell lymphoma JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-05-282780 DO - 10.1182/blood-2010-05-282780 ID - Green2010 ER - TY - JOUR AU - Danilova, L. AU - Wang, H. AU - Sunshine, J. AU - Kaunitz, G. J. AU - Cottrell, T. R. AU - Xu, H. PY - 2016 DA - 2016// TI - Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1607836113 DO - 10.1073/pnas.1607836113 ID - Danilova2016 ER -